Morales Vargas Centro de Investigacion, S.C.
Leon, Guanajuato, Mexico
Wellness program in León
Blvd. Adolfo López Mateos 218, Obregon, 37320 León, Gto.
About Morales Vargas Centro de Investigacion, S.C.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Takeda
4
EMD Serono
2
Eli Lilly and Company
2
Janssen Research & Development, LLC
2
Amgen
1
EMD Serono Research & Development Institute, Inc.
1
Guerbet
1
Horizon Therapeutics Ireland DAC
1
Idorsia Pharmaceuticals Ltd.
1
Kirby Institute
1
Pfizer
1
Clinical Trials at Morales Vargas Centro de Investigacion, S.C.
During the past decade, Morales Vargas Centro de Investigacion, S.C. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on
average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
2013-12-01
2016-09-01
Completed
306
Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors
2014-06-01
2015-09-01
Completed
279
Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)
2014-07-29
2018-02-09
Terminated
253
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
2015-06-29
2019-01-18
Completed
771
Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)
2016-01-04
2019-08-06
Completed
644
Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
2015-12-18
2018-08-21
Completed
383
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
2016-04-15
2023-05-06
Active, not recruiting
746
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Morales Vargas Centro de Investigacion, S.C." #1 sponsor was "Takeda" with 4 trials, followed by "EMD Serono" with 2 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Morales Vargas Centro de Investigacion, S.C."
#1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Janssen Pharmaceutica" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "National Health and Medical Research Council, Australia" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Morales Vargas Centro de Investigacion, S.C.
According to Clinical.Site data, the most researched conditions in "Morales Vargas Centro de Investigacion, S.C." are
"Systemic Lupus Erythematosus" (6 trials), "Colitis, Ulcerative" (3 trials), "Lupus Erythematosus, Systemic" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Morales Vargas Centro de Investigacion, S.C." in a lesser frequency.
Clinical Trials Intervention Types at Morales Vargas Centro de Investigacion, S.C.
Most popular intervention types in "Morales Vargas Centro de Investigacion, S.C." are "Drug" (17 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Amivantamab" (2 trials), "Atacicept 150 mg" (2 trials), "Baricitinib" (2 trials) and "Lazertinib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Morales Vargas Centro de Investigacion, S.C.
The vast majority of trials in "Morales Vargas Centro de Investigacion, S.C." are
18 trials for "All" genders.
Clinical Trials Status at Morales Vargas Centro de Investigacion, S.C.
Currently, there are NaN active trials in "Morales Vargas Centro de Investigacion, S.C.".
undefined are not yet recruiting,
1 are recruiting,
6 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 6 completed trials in Morales Vargas Centro de Investigacion, S.C.,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Morales Vargas Centro de Investigacion, S.C., 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".